EQS-News: Heidelberg Pharma AG / Key word(s): Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 25.04.2024 / 07:21 CET/CEST The issuer is solely responsible for the content of this announcement. Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 First efficacy data from the clinical trial with HDP-101 in multiple myeloma Professor Andreas Pahl becomes Chief Executive Officer Successful financing activities Sale of a portion of future royalties for Zircaix™ to HealthCare...
EQS-News: Heidelberg Pharma AG / Schlagwort(e): Quartals-/Zwischenmitteilung Heidelberg Pharma AG berichtet über die ersten drei Monate 2024 25.04.2024 / 07:21 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Heidelberg Pharma AG berichtet über die ersten drei Monate 2024 Erste Wirksamkeitsdaten der klinischen Studie mit HDP-101 im Multiplen Myelom Prof. Dr. Andreas Pahl wird Sprecher des Vorstands Erfolgreiche Finanzierungsaktivitäten Verkauf eines Teils der zukünftigen Lizenzgebühren für Zircaix™ an HealthCare Royalty finanziert...
Two Directors at Westamerica Bancorporation bought/sold/maiden bought 1,308 shares at between 47.240USD and 47.805USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all th...
A director at Regions Financial Corp bought 50,000 shares at 19.370USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
SMCP - 2024 Q1 Sales 2024 first quarterPress release - Paris, April 25th, 2024 Q1 sales down by 5% in a macroeconomic environment that remains challengingDetailing the action plan to deliver growth and profitability First quarter sales Q1 2024 sales at €287m, decreasing by -5% on an organic basis vs Q1 2023, against strong comparables.Good performance in America, resilience in Europe (excl. France) and slow consumption in ChinaSandro and Maje slight organic growth excluding ChinaMaintained stringent discount rate policy, with a 2 points improvement of the in-season discount rate...
SMCP - Chiffre d'affaires T1 2024 Premier trimestre 2024Communiqué - Paris, le 25 avril 2024 Ventes du premier trimestre en recul de 5%dans un environnement macroéconomique toujours dégradé Détail du plan d’actions au service de la croissance et de la rentabilité Ventes du premier trimestre Chiffre d’affaires de 287 M€ au premier trimestre, en recul de -5% en organique par rapport au premier trimestre 2023, qui constituait une base de comparaison élevéeBonne performance en Amérique, résilience en Europe (hors France) et consommation toujours ralentie en Chine Sandro et Maje en lé...
EQS-News: HelloFresh SE / Schlagwort(e): Quartals-/Zwischenmitteilung HelloFresh SE vermeldet Quartalsumsatz von ca. €2,07 Mrd. / Produktkategorie für Fertiggerichte wächst zügig und expandiert in weitere Länder 25.04.2024 / 07:09 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. HelloFresh SE vermeldet Quartalsumsatz von ca. €2,07 Mrd. Produktkategorie für Fertiggerichte wächst zügig und expandiert in weitere Länder Im ersten Quartal 2024 erreichte die HelloFresh Gruppe einen Umsatz von ca. €2,07 Milliarden, ein währungsbereini...
EQS-News: HelloFresh SE / Key word(s): Quarterly / Interim Statement HelloFresh SE reports quarterly revenue of approx. €2.07 bn Ready-to-Eat product category growing quickly and expanding to further countries 25.04.2024 / 07:09 CET/CEST The issuer is solely responsible for the content of this announcement. HelloFresh SE reports quarterly revenue of approx. €2.07 bn Ready-to-Eat product category growing quickly and expanding to further countries In Q1 2024 the HelloFresh Group achieved approx. €2.07 billion of revenue, a constant currency revenue growth of 3.8%, s...
EQS-News: STRABAG SE / Key word(s): Annual Results STRABAG SE: Higher net income despite declining markets in 2023 25.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. STRABAG SE: Higher net income despite declining markets in 2023 New record output of € 19.1 billion (+8% vs. 2022) High order backlog largely unchanged at € 23.5 billion EBIT margin above expectations at 5.0% Higher dividend of € 2.20 proposed Outlook for 2024: output volume of around € 19.4 billion, EBIT margin ≥ 4% STRABAG publishes its first online Ann...
EQS-News: HELLA GmbH & Co. KGaA / Key word(s): Quarter Results/Quarterly / Interim Statement First quarter of 2024: FORVIA HELLA increases sales and maintains profitability at prior-year level; Company outlook confirmed 25.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. LIPPSTADT (GERMANY) 25 April 2024 First quarter of 2024: FORVIA HELLA increases sales and maintains profitability at prior-year level; Company outlook confirmed Currency-adjusted sales increase by 2.2 percent to €2.0 billion; reported growth of ...
EQS-News: HELLA GmbH & Co. KGaA / Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung Erstes Quartal 2024: FORVIA HELLA steigert Umsatz und hält Profitabilität auf Vorjahresniveau; Unternehmensausblick bestätigt 25.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. LIPPSTADT (DEUTSCHLAND) 25. April 2024 Erstes Quartal 2024: FORVIA HELLA steigert Umsatz und hält Profitabilität auf Vorjahresniveau; Unternehmensausblick bestätigt Umsatz steigt währungsbereinigt um 2,2 Prozent auf 2,0 Milliarden Euro; b...
EQS-News: STRABAG SE / Schlagwort(e): Jahresergebnis STRABAG SE: Höheres Konzernergebnis trotz rückläufiger Märkte in 2023 25.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STRABAG SE: Höheres Konzernergebnis trotz rückläufiger Märkte in 2023 Neue Rekordleistung von € 19,1 Mrd. (+8 % vs. 2022) Hoher Auftragsbestand nahezu stabil bei € 23,5 Mrd. EBIT-Marge mit 5,0 % über den Erwartungen Höhere Dividende von € 2,20 vorgeschlagen Ausblick 2024: Leistung rd. € 19,4 Mrd., EBIT-Marge ≥ 4 % STRABAG veröffentlicht erstma...
A director at GigaCloud Technology Inc sold 88,000 shares at 36.173USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
A director at DraftKings Inc sold 200,000 shares at 40.910USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Lucror Analytics Convertibles Briefs comprise fundamental credit analysis, opinions and trade recommendations on convertible bond issuers, based on key company-specific developments in the past 24 hours. The publication includes a section with a brief market commentary, key market indicators, and a corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.